Wen Tan
- Cancer Research top 0.5%
- Carcinogens and Genotoxicity Assessment 10
- Oncology top 1%
- Cancer-related Molecular Pathways 10
- Pancreatic and Hepatic Oncology Research 8
- Molecular Biology top 2%
- RNA modifications and cancer 24
- DNA Repair Mechanisms 21
- Epigenetics and DNA Methylation 18
- Cancer-related gene regulation 15
-
- Genetic factors in colorectal cancer 12
- Genetics top 2%
- Journals
- Nature Communications (2 papers)Nature Genetics (3 papers)The Journal of Experimental Medicine (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wen Tan
122 papers receiving 6.2k citations
Peers
Comparison fields: 5 of 140
- Cancer Research 2.1k
- Oncology 1.8k
- Molecular Biology 3.9k
- Pathology and Forensic Medicine 591
- Genetics 744
Countries citing papers authored by Wen Tan
This map shows the geographic impact of Wen Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Tan more than expected).
Fields of papers citing papers by Wen Tan
This network shows the impact of papers produced by Wen Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Tan. The network helps show where Wen Tan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wen Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 17 | |
| 2 | 2023 | 23 | |
| 3 | 2023 | 5 | |
| 4 | 2020 | 56 | |
| 5 | 2019 | 1 | |
| 6 | 2013 | 27 | |
| 7 | [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism]. | 2013 | 2 |
| 8 | 2012 | 10 | |
| 9 | 2011 | 60 | |
| 10 | 2010 | 39 | |
| 11 | 2009 | 114 | |
| 12 | 2009 | 36 | |
| 13 | 2009 | 15 | |
| 14 | 2008 | 104 | |
| 15 | 2008 | 44 | |
| 16 | 2008 | 138 | |
| 17 | 2008 | 21 | |
| 18 | 2007 | 218 | |
| 19 | 2006 | 91 | |
| 20 | 2005 | 97 |
About Wen Tan
Wen Tan is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 125 papers that have together received 6.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (24 papers), DNA Repair Mechanisms (21 papers), Epigenetics and DNA Methylation (18 papers), Cancer-related gene regulation (15 papers), Genetic factors in colorectal cancer (12 papers), Cancer-related Molecular Pathways (10 papers), Carcinogens and Genotoxicity Assessment (10 papers) and Pancreatic and Hepatic Oncology Research (8 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (1.8k citations) and Molecular Biology (3.9k citations). Wen Tan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Dongxin Lin, Xiaoping Miao, Dianke Yu, Chen Wu, Xuemei Zhang, Ming Yang, Deyin Xing, Yifeng Zhou, Chun-Yuan Yu and Yongli Guo. Their work appears in journals such as Nature Communications, Nature Genetics and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.